Perspective Therapeutics announced FDA Fast Track Designation for PSV359 to treat advanced FAP-positive solitary fibrous ...

Options trading asks far more of a platform than a standard trading account can deliver. What you need is software built ...

Find the best free trading journal in 2026. We compare 6 free platforms for day trading, forex, options, and beginners to ...

Find the best trading journal for beginners and learn what to track. Compare platforms ranked by trade import, AI assistants, ...

RBC Capital downgrades to ‘Sector Perform’ from ‘Outperform’ and cuts price target to $1 from $10. ・Caribou will also reduce its workforce. ・The company had $113.8 million in cash, cash equivalents ...

One targets defense software with mounting losses, while the other is going after a $1 trillion GPU cloud opportunity.

CD&R, McKesson Corporation (NYSE: MCK) ("McKesson"), and Option Care Health, Inc. (Nasdaq: OPCH) ("Option Care Health") announced today that they have entered into a definitive agreement, under which ...

Crescent Biopharma's CR-002 clinical trial for advanced solid tumors set to begin Q4 2026, with initial data due mid-2027.

Richardson Electronics gets a Hold rating, awaiting consistent profitability and free cash flow before considering a more bullish stance. Read more on RELL.

FINRA-Stanford study of 2,861 investors: 54 percent with basic literacy would take a 'guaranteed' 25% return, vs 35 percent ...

Space Exploration Technologies Corp. stocks have been trading up by 2.89 percent after securing a major new launch contract.